M C53 (Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg)
Pill with imprint M C53 is Green, Round and has been identified as Carbidopa and Levodopa (Orally Disintegrating) 25 mg / 250 mg. It is supplied by Mylan Pharmaceuticals Inc.
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M C53
Carbidopa and Levodopa (Orally Disintegrating)
- Imprint
- M C53
- Strength
- 25 mg / 250 mg
- Color
- Green
- Size
- 15.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-5053 (Discontinued)
- Inactive Ingredients
-
aspartame,
mannitol,
microcrystalline cellulose,
silicon dioxide,
sodium stearyl fumarate,
sorbitol,
FD&C Blue No. 1,
D&C Yellow No. 10
Note: Inactive ingredients may vary.
More about carbidopa / levodopa
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (85)
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
- Drug Information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
- Other brands
- Sinemet, Rytary, Duopa, Sinemet CR, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.